These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Gut microbiota in burned patients with Clostridioides difficile infection. Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229 [TBL] [Abstract][Full Text] [Related]
10. Integrating gut microbiome and host immune markers to understand the pathogenesis of Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169 [No Abstract] [Full Text] [Related]
11. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients. Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360 [TBL] [Abstract][Full Text] [Related]
12. Disordered Intestinal Microbial Communities During Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508 [TBL] [Abstract][Full Text] [Related]
13. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Hawes AM; Desai A; Patel PK Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702 [TBL] [Abstract][Full Text] [Related]
14. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities. Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161 [TBL] [Abstract][Full Text] [Related]
15. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance. Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964 [TBL] [Abstract][Full Text] [Related]
16. Fidaxomicin for the treatment of Skinner AM; Scardina T; Kociolek LK Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754 [TBL] [Abstract][Full Text] [Related]
17. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525 [TBL] [Abstract][Full Text] [Related]
18. Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis. Kazakova SV; Baggs J; McDonald LC; Yi SH; Hatfield KM; Guh A; Reddy SC; Jernigan JA Clin Infect Dis; 2020 Jan; 70(1):11-18. PubMed ID: 30820545 [TBL] [Abstract][Full Text] [Related]
19. Association between Antibiotic Consumption and Incidence of Kim B; Kim J; Pai H J Korean Med Sci; 2020 Dec; 35(47):e407. PubMed ID: 33289370 [TBL] [Abstract][Full Text] [Related]
20. Investigation of a cluster of Clostridium difficile infections in a pediatric oncology setting. Dantes R; Epson EE; Dominguez SR; Dolan S; Wang F; Hurst A; Parker SK; Johnston H; West K; Anderson L; Rasheed JK; Moulton-Meissner H; Noble-Wang J; Limbago B; Dowell E; Hilden JM; Guh A; Pollack LA; Gould CV Am J Infect Control; 2016 Feb; 44(2):138-45. PubMed ID: 26601705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]